The Vanguard Health Care ETF (VHT) has shown remarkable activity in its underlying holdings, with a notable 21.3% of these holdings experiencing insider buying over the past six months. This trend is often seen as a positive indicator, suggesting that those with the most insight into the companies believe in their future potential.
One of the standout companies within this ETF is UnitedHealth Group Inc (Symbol: UNH), which constitutes 5.26% of VHT’s portfolio. Recent Form 4 data reveals that five directors and officers have purchased shares in the last six months. The ETF holds a substantial $910,662,264 worth of UNH, making it the fourth largest holding in the fund. Below is a detailed table showcasing the recent insider buying activity at UNH:
UNH — last trade: $359.93 — Recent Insider Buys:
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 05/15/2025 | Kristen Gil | Director | 3,700 | $271.17 | $1,003,329 |
| 05/14/2025 | John H. Noseworthy | Director | 300 | $312.16 | $93,647 |
| 05/14/2025 | Timothy Patrick Flynn | Director | 1,533 | $320.80 | $491,786 |
| 05/16/2025 | John F. Rex | President & CFO | 17,175 | $291.12 | $4,999,919 |
| 05/16/2025 | Stephen J. Hemsley | CEO, UHG | 86,700 | $288.57 | $25,019,019 |
Another noteworthy company is Illumina Inc (Symbol: ILMN), which ranks as the 52nd largest holding within the Vanguard Health Care ETF. The ETF holds $44,761,235 worth of ILMN, accounting for approximately 0.26% of its total assets. Recent insider buying activity at ILMN is summarized in the table below:
ILMN — last trade: $91 — Recent Insider Buys:
| Purchased | Insider | Title | Shares | Price/Share | Value |
|---|---|---|---|---|---|
| 05/12/2025 | Ankur Dhingra | SVP, Chief Financial Officer | 6,100 | $81.21 | $495,381 |
| 05/13/2025 | Jacob Thaysen | Chief Executive Officer | 12,350 | $80.86 | $998,674 |
10 ETFs With Stocks That Insiders Are Buying »
Also see:
• BURL YTD Return
• Institutional Holders of SVMH
• DUSL shares outstanding history
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
